These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2186581)

  • 1. Analysis of variables of plasmid transformation of a bacterial vaccine: studies on recombinant BCG.
    Lugosi L
    Vaccine; 1990 Apr; 8(2):145-9. PubMed ID: 2186581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transformation of BCG with plasmid DNA.
    Lugosi L; Jacobs W; Bloom BR
    Acta Leprol; 1989; 7 Suppl 1():256-7. PubMed ID: 2503999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic transformation of BCG.
    Lugosi L; Jacobs WR; Bloom BR
    Tubercle; 1989 Sep; 70(3):159-70. PubMed ID: 2694552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors affecting transformation efficiency of BCG with a Mycobacterium-Escherichia coli shuttle vector pYUB18 by electroporation.
    Cho SN; Hwang JH; Park S; Chong Y; Kim SK; Song CY; Kim JD
    Yonsei Med J; 1998 Apr; 39(2):141-7. PubMed ID: 9587254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Auxotrophic complementation as a selectable marker for stable expression of foreign antigens in Mycobacterium bovis BCG.
    Borsuk S; Mendum TA; Fagundes MQ; Michelon M; Cunha CW; McFadden J; Dellagostin OA
    Tuberculosis (Edinb); 2007 Nov; 87(6):474-80. PubMed ID: 17888740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant Mycobacterium bovis BCG.
    Bastos RG; Borsuk S; Seixas FK; Dellagostin OA
    Vaccine; 2009 Nov; 27(47):6495-503. PubMed ID: 19720367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycobacterium bovis BCG-based vaccines against tuberculosis: novel developments.
    Dietrich G; Viret JF; Hess J
    Vaccine; 2003 Jan; 21(7-8):667-70. PubMed ID: 12531337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant BCG as a candidate oral vaccine vector.
    Barletta RG; Snapper B; Cirillo JD; Connell ND; Kim DD; Jacobs WR; Bloom BR
    Res Microbiol; 1990; 141(7-8):931-9. PubMed ID: 2101484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crucial requirement for standardization during the development of novel recombinant BCG vaccines: Does the corresponding substrain background matter?
    Antas PR
    Hum Vaccin Immunother; 2016 Dec; 12(12):3099-3102. PubMed ID: 27454883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Construction of recombinant BCG bearing Schistosoma japonicum 26Ku antigen gene and study on its immunogenicity on mice].
    Dai W; Huangfu Y; Zheng B
    Zhonghua Yi Xue Za Zhi; 2000 Jun; 80(6):407-10. PubMed ID: 11798793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of Genome Region of Difference 4 (RD4) on Mycobacterial Virulence and BCG Efficacy.
    Ru H; Liu X; Lin C; Yang J; Chen F; Sun R; Zhang L; Liu J
    Front Cell Infect Microbiol; 2017; 7():239. PubMed ID: 28642843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of BCG as a live recombinant vector system: potential use as an HIV vaccine.
    Fuerst TR; Stover CK; de la Cruz VF
    Biotechnol Ther; 1991; 2(1-2):159-78. PubMed ID: 1845119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of substrains of BCG vaccine using multiplex PCR.
    Bedwell J; Kairo SK; Behr MA; Bygraves JA
    Vaccine; 2001 Feb; 19(15-16):2146-51. PubMed ID: 11228387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of the Mycobacterium bovis BCG vaccine: review of the historical and biochemical evidence for a genealogical tree.
    Oettinger T; Jørgensen M; Ladefoged A; Hasløv K; Andersen P
    Tuber Lung Dis; 1999; 79(4):243-50. PubMed ID: 10692993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stable expression of Leptospira interrogans antigens in auxotrophic Mycobacterium bovis BCG.
    Seixas FK; Borsuk S; Fagundes MQ; Hartwig DD; Da Silva EF; Cerqueira GM; Dellagostin OA
    Biol Res; 2010; 43(1):13-8. PubMed ID: 21157628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microevolution of BCG substrains.
    Krysztopa-Grzybowska K; Lutyńska A
    Postepy Hig Med Dosw (Online); 2016 Dec; 70(0):1259-1266. PubMed ID: 28026828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Manipulation of BCG vaccine: a double-edged sword.
    Singh VK; Srivastava R; Srivastava BS
    Eur J Clin Microbiol Infect Dis; 2016 Apr; 35(4):535-43. PubMed ID: 26810060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiplex-PCR as an identity assay for Mycobacterium bovis BCG Moreau descendants.
    Krysztopa-Grzybowska K; Brzezińska S; Augustynowicz-Kopeć E; Polak M; Lutyńska A
    Biologicals; 2013 May; 41(3):197-200. PubMed ID: 23490534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving the Immunogenicity of the Mycobacterium bovis BCG Vaccine by Non-Genetic Bacterial Surface Decoration Using the Avidin-Biotin System.
    Liao TY; Lau A; Joseph S; Hytönen V; Hmama Z
    PLoS One; 2015; 10(12):e0145833. PubMed ID: 26716832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene replacement by homologous recombination in Mycobacterium bovis BCG.
    Norman E; Dellagostin OA; McFadden J; Dale JW
    Mol Microbiol; 1995 May; 16(4):755-60. PubMed ID: 7476169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.